Piovesana, Ester
Magrin, Claudia
Ciccaldo, Matteo
Sola, Martina
Bellotto, Manolo
Molinari, Maurizio
Papin, Stéphanie
Paganetti, Paolo
Funding for this research was provided by:
Innosuisse-Schweizerische Agentur für Innovationsförderung (Project 35449.1 IP-LS)
Gelu Foundation
Charitable Gabriel Foundation
Article History
Received: 23 May 2023
Accepted: 14 October 2023
First Online: 21 October 2023
Competing interests
: The authors declare no competing interests. Manolo Bellotto is an employee of GT Gain Therapeutics SA.